1-11 of 11
Authors: the Swiss HIV Cohort Study
Save search
Sort by
Journal Article

Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration Open Access

PDF
Paul Thoueille and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1433–1443, https://doi.org/10.1093/jac/dkad103
Published: 12 April 2023
Journal Article

Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study Free

PDF
Bernadette Jakeman and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 2, February 2022, Pages 492–499, https://doi.org/10.1093/jac/dkab386
Published: 03 November 2021
Journal Article
EDITOR'S CHOICE

Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity Free

PDF
Françoise Livio and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 3, March 2021, Pages 758–764, https://doi.org/10.1093/jac/dkaa505
Published: 05 December 2020
Journal Article

Real-life management of drug–drug interactions between antiretrovirals and statins Free

PDF
Perrine Courlet and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 7, July 2020, Pages 1972–1980, https://doi.org/10.1093/jac/dkaa099
Published: 02 April 2020
Journal Article

Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland Free

PDF
Nadine Bachmann and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 2, February 2019, Pages 468–472, https://doi.org/10.1093/jac/dky436
Published: 21 November 2018
Journal Article

Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors? Free

PDF
K. Kletenkov and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 3, March 2017, Pages 866–875, https://doi.org/10.1093/jac/dkw493
Published: 15 December 2016
Journal Article

Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals Free

PDF
Catalina Barceló and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 7, July 2016, Pages 1933–1942, https://doi.org/10.1093/jac/dkw050
Published: 29 March 2016
Journal Article

Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study Free

PDF
Wan-Lin Yang and others
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 12, December 2015, Pages 3323–3331, https://doi.org/10.1093/jac/dkv257
Published: 11 September 2015
Journal Article

Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals Get access

PDF
M. Arab-Alameddine and others
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 9, September 2014, Pages 2489–2498, https://doi.org/10.1093/jac/dku131
Published: 12 May 2014
Journal Article

Ageing with HIV: medication use and risk for potential drug–drug interactions Get access

PDF
Catia Marzolini and others
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 9, September 2011, Pages 2107–2111, https://doi.org/10.1093/jac/dkr248
Published: 16 June 2011
Journal Article

Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy Get access

PDF
Peter P. Sendi and others
Journal of Antimicrobial Chemotherapy, Volume 44, Issue 6, December 1999, Pages 811–817, https://doi.org/10.1093/jac/44.6.811
Published: 01 December 1999